Telogen Effluvium Associated with Albendazole Therapy

    M. Pilar García-Muret, Dolors Sitjas, Laura Tuneu, J. M. De Moragas
    Image of study
    TLDR Albendazole may cause hair loss.
    In 1990, a 59-year-old woman undergoing albendazole therapy for hydatid disease at a daily dose of 400 mg developed telogen effluvium, a non-scarring form of hair loss. Clinical examination revealed a high number of telogen hairs, with no signs of inflammation or scarring, and laboratory tests excluded other causes for the hair loss. The patient's condition improved after the dosage of albendazole was reduced and then discontinued, indicating a link between the medication and hair loss. This case underscores the importance for dermatologists to recognize hair loss as a possible side effect of albendazole treatment.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 419 results

    Similar Research

    5 / 1000+ results
      Diseases of Hair and Nails

      research Diseases of Hair and Nails

      3 citations, January 2012 in “Elsevier eBooks”
      The document says that there are treatments for hair and nail diseases.
      Chemically Induced Hair Loss/Alopecia

      research Chemically Induced Hair Loss/Alopecia

      January 2019 in “Springer eBooks”
      Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.
      Albendazole-Induced Anagen Effluvium

      research Albendazole-Induced Anagen Effluvium

      5 citations, December 2019 in “JAAD Case Reports”
      A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.
      Index

      research Index

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      The document is a detailed medical reference on skin and genetic disorders.